197 related articles for article (PubMed ID: 28775076)
1. The Involvement of miRNA in Carotid-Related Stroke.
Maitrias P; Metzinger-Le Meuth V; Nader J; Reix T; Caus T; Metzinger L
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1608-1617. PubMed ID: 28775076
[TBL] [Abstract][Full Text] [Related]
2. microRNAs in Cerebrovascular Disease.
Volný O; Kašičková L; Coufalová D; Cimflová P; Novák J
Adv Exp Med Biol; 2015; 888():155-95. PubMed ID: 26663183
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA deregulation in symptomatic carotid plaque.
Maitrias P; Metzinger-Le Meuth V; Massy ZA; M'Baya-Moutoula E; Reix T; Caus T; Metzinger L
J Vasc Surg; 2015 Nov; 62(5):1245-50.e1. PubMed ID: 26238333
[TBL] [Abstract][Full Text] [Related]
4. [MicroRNA in ischemic stroke].
Aitbaev KA; Murkamilov IT; Fomin VV; Murkamilova JA; Yusupov FA
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3. Vyp. 2):48-56. PubMed ID: 29798981
[TBL] [Abstract][Full Text] [Related]
5. Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processes.
Pende A; Dallegri F
Curr Vasc Pharmacol; 2015; 13(2):173-81. PubMed ID: 24188488
[TBL] [Abstract][Full Text] [Related]
6. microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.
Badacz R; Przewłocki T; Legutko J; Żmudka K; Kabłak-Ziembicka A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555285
[TBL] [Abstract][Full Text] [Related]
7. A unique microRNA signature associated with plaque instability in humans.
Cipollone F; Felicioni L; Sarzani R; Ucchino S; Spigonardo F; Mandolini C; Malatesta S; Bucci M; Mammarella C; Santovito D; de Lutiis F; Marchetti A; Mezzetti A; Buttitta F
Stroke; 2011 Sep; 42(9):2556-63. PubMed ID: 21817153
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as sentinels and protagonists of carotid artery thromboembolism.
Raju S; Fish JE; Howe KL
Clin Sci (Lond); 2020 Jan; 134(2):169-192. PubMed ID: 31971230
[TBL] [Abstract][Full Text] [Related]
9. microRNA therapeutics in cardiovascular disease models.
Dangwal S; Thum T
Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease.
Tsai PC; Liao YC; Wang YS; Lin HF; Lin RT; Juo SH
J Vasc Res; 2013; 50(4):346-54. PubMed ID: 23860376
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide meta-analysis identifies novel loci of plaque burden in carotid artery.
Pott J; Burkhardt R; Beutner F; Horn K; Teren A; Kirsten H; Holdt LM; Schuler G; Teupser D; Loeffler M; Thiery J; Scholz M
Atherosclerosis; 2017 Apr; 259():32-40. PubMed ID: 28282560
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy.
Mirzaei H; Momeni F; Saadatpour L; Sahebkar A; Goodarzi M; Masoudifar A; Kouhpayeh S; Salehi H; Mirzaei HR; Jaafari MR
J Cell Physiol; 2018 Feb; 233(2):856-865. PubMed ID: 28067403
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.
Welten SMJ; de Jong RCM; Wezel A; de Vries MR; Boonstra MC; Parma L; Jukema JW; van der Sluis TC; Arens R; Bot I; Agrawal S; Quax PHA; Nossent AY
Atherosclerosis; 2017 Jun; 261():26-36. PubMed ID: 28445809
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Regulation of Atherosclerosis.
Feinberg MW; Moore KJ
Circ Res; 2016 Feb; 118(4):703-20. PubMed ID: 26892968
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
16. microRNAs: innovative targets for cerebral ischemia and stroke.
Ouyang YB; Stary CM; Yang GY; Giffard R
Curr Drug Targets; 2013 Jan; 14(1):90-101. PubMed ID: 23170800
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease.
Persson M; Östling G; Smith G; Hamrefors V; Melander O; Hedblad B; Engström G
Stroke; 2014 Jan; 45(1):18-23. PubMed ID: 24253546
[TBL] [Abstract][Full Text] [Related]
18. miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics.
Elballal MS; Mohammed OA; Zaki MB; Abulsoud AI; Tabaa MME; Elazazy O; Abd-Elmawla MA; El-Dakroury WA; Abdel Mageed SS; Rashad AA; Abdelmaksoud NM; Elrebehy MA; Nomier Y; Abdel-Reheim MA; Oraby MA; Doghish AS
Pathol Res Pract; 2024 Jan; 253():155093. PubMed ID: 38184962
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic Analysis of Potential microRNAs in Ischemic Stroke.
He W; Chen S; Chen X; Li S; Chen W
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1753-1759. PubMed ID: 27151415
[TBL] [Abstract][Full Text] [Related]
20. In search of a marker of vulnerable carotid plaque: is the key in the heart?
Petretta M; Cuocolo A
Atherosclerosis; 2012 Jul; 223(1):95-7. PubMed ID: 22369935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
